Improved Revenues Required Before Syntara Limited (ASX:SNT) Stock's 36% Jump Looks Justified
Jul 05
Australian (ASX) Pharma Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies29
- 7D-1.4%
- 3M28.6%
- 1Y63.4%
- YTD14.9%
Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from Neuren Pharmaceuticals of 3.3%. This takes the industry's 12 month performance to a gain of 63%. Earnings are forecast to grow by 39% annually.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | AU$6.8b | AU$995.3m | -AU$387,920,108.00 | 11.6x | -17.5x | 6.8x |
| Sun, 23 Jun 2024 | AU$6.1b | AU$995.3m | -AU$387,920,108.00 | 11.8x | -15.7x | 6.1x |
| Tue, 21 May 2024 | AU$6.3b | AU$1.2b | -AU$374,923,684.00 | 13.3x | -16.7x | 5.1x |
| Thu, 18 Apr 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 14.9x | -14.9x | 4.6x |
| Sat, 16 Mar 2024 | AU$5.5b | AU$1.2b | -AU$380,850,666.00 | 14.6x | -14.5x | 4.5x |
| Mon, 12 Feb 2024 | AU$5.6b | AU$892.7m | -AU$536,464,511.00 | 20.7x | -10.5x | 6.3x |
| Wed, 10 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.3x | -9.6x | 6.3x |
| Fri, 08 Dec 2023 | AU$4.3b | AU$896.3m | -AU$589,604,392.00 | 17.5x | -7.4x | 4.8x |
| Sun, 05 Nov 2023 | AU$3.7b | AU$893.0m | -AU$595,020,018.00 | 18.5x | -6.2x | 4.1x |
| Tue, 03 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.6x | -6x | 3.9x |
| Thu, 31 Aug 2023 | AU$4.2b | AU$1.1b | -AU$601,971,667.00 | 19.4x | -6.9x | 3.8x |
| Sat, 29 Jul 2023 | AU$4.2b | AU$999.0m | -AU$624,794,303.00 | 22.4x | -6.8x | 4.2x |
| Mon, 26 Jun 2023 | AU$3.9b | AU$999.0m | -AU$624,794,303.00 | 21.3x | -6.2x | 3.9x |
| Wed, 24 May 2023 | AU$4.2b | AU$993.2m | -AU$640,306,659.00 | 19x | -6.5x | 4.2x |
| Fri, 21 Apr 2023 | AU$4.1b | AU$993.2m | -AU$641,969,868.00 | 18.2x | -6.4x | 4.2x |
| Sun, 19 Mar 2023 | AU$4.1b | AU$995.9m | -AU$648,651,745.00 | 18.7x | -6.3x | 4.1x |
| Tue, 14 Feb 2023 | AU$3.6b | AU$950.3m | -AU$584,061,383.00 | 17.1x | -6.2x | 3.8x |
| Thu, 12 Jan 2023 | AU$4.1b | AU$948.3m | -AU$544,428,006.00 | 13.2x | -7.6x | 4.4x |
| Sat, 10 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,005.00 | 13.1x | -7.1x | 4.1x |
| Mon, 07 Nov 2022 | AU$4.2b | AU$948.3m | -AU$544,428,005.00 | 12.8x | -7.8x | 4.5x |
| Wed, 05 Oct 2022 | AU$4.1b | AU$946.2m | -AU$548,400,005.00 | 12.1x | -7.4x | 4.3x |
| Fri, 02 Sep 2022 | AU$3.9b | AU$937.3m | -AU$530,706,609.00 | 12.9x | -7.4x | 4.2x |
| Sun, 31 Jul 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15.3x | -11.1x | 4.8x |
| Tue, 28 Jun 2022 | AU$3.2b | AU$818.2m | -AU$353,932,589.00 | 12.3x | -9.2x | 4x |
| Thu, 26 May 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15x | -11.1x | 4.8x |
| Sat, 23 Apr 2022 | AU$4.2b | AU$800.9m | -AU$348,637,558.00 | 16.2x | -12x | 5.2x |
| Mon, 21 Mar 2022 | AU$4.4b | AU$799.2m | -AU$341,805,125.00 | 17.2x | -12.8x | 5.5x |
| Wed, 16 Feb 2022 | AU$4.6b | AU$749.0m | -AU$464,190,190.00 | 20.5x | -9.9x | 6.1x |
| Fri, 14 Jan 2022 | AU$5.0b | AU$758.4m | -AU$450,516,414.00 | 21.5x | -11.2x | 6.6x |
| Sun, 12 Dec 2021 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 25.2x | -10.8x | 6.4x |
| Tue, 09 Nov 2021 | AU$5.0b | AU$758.4m | -AU$447,307,205.00 | 23.7x | -11.1x | 6.5x |
| Thu, 07 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.7x | -10.4x | 6.2x |
| Sat, 04 Sep 2021 | AU$4.9b | AU$756.0m | -AU$452,225,384.00 | 22x | -10.8x | 6.4x |
| Mon, 02 Aug 2021 | AU$4.2b | AU$752.8m | -AU$442,004,016.00 | 20.9x | -9.4x | 5.5x |
Price to Earnings Ratio
-9.4x
Current Industry PE
- Investors are optimistic on the Australian Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.0x is lower than the industry's current PS ratio of 6.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 9.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | -2.20% | |
| Healthcare | -1.08% | |
| Pharma | -1.36% | |
| Pharma | -1.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BOT Botanix Pharmaceuticals | AU$0.38 | 1.4% +AU$9.1m | 188.5% | PS1552.5x | |
| SNT Syntara | AU$0.041 | 7.9% +AU$3.6m | -18.0% | PS2.5x | |
| CAN Cann Group | AU$0.034 | 17.2% +AU$2.3m | -74.8% | PS0.7x | |
| VIT Vitura Health | AU$0.093 | 2.2% +AU$1.2m | -81.4% | PE5.7x | |
| ACR Acrux | AU$0.069 | 3.0% +AU$581.4k | 35.3% | PS1.8x |
